Log in

Relevant bibliographies by topics / Viral disease / Journal articles

To see the other types of publications on this topic, follow the link: Viral disease.

Journal articles on the topic 'Viral disease'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Viral disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Montague, Terrence J., Gary D. Lopaschuk, and Norman J. Davies. "Viral Heart Disease." Chest 98, no. 1 (1990): 190–99. http://dx.doi.org/10.1378/chest.98.1.190.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Severson, Jessica L., and Stephen K. Tyring. "Viral disease update." Current Problems in Dermatology 11, no. 2 (1999): 37–70. http://dx.doi.org/10.1016/s1040-0486(99)90007-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Gulbahce, Natali, Han Yan, Marc Vidal, and Albert-Laszlo Barabasi. "Viral Disease Networks." Biophysical Journal 98, no. 3 (2010): 196a. http://dx.doi.org/10.1016/j.bpj.2009.12.1040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Stovin, P. "Viral Heart Disease." Journal of Clinical Pathology 38, no. 3 (1985): 358. http://dx.doi.org/10.1136/jcp.38.3.358-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Billiau, A. "Viral heart disease." Antiviral Research 5, no. 1 (1985): 63. http://dx.doi.org/10.1016/0166-3542(85)90019-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

TAPPER, M. L. "Emerging viral diseases and infectious disease risks." Haemophilia 12, s1 (2006): 3–7. http://dx.doi.org/10.1111/j.1365-2516.2006.01194.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Franchini, Genoveffa, Richard F. Ambinder, and Michèle Barry. "Viral Disease in Hematology." Hematology 2000, no. 1 (2000): 409–23. http://dx.doi.org/10.1182/asheducation.v2000.1.409.20000409.

Full text

Abstract:

As part of the international outreach of the American Society of Hematology, this review addresses some aspects of the genetics, biology, epidemiology, and clinical relevance of viruses that cause a variety of hematopoietic disorders in human populations. The viruses described here have a different pattern of geographical distribution, and the disease manifestations may vary according to environmental and/or genetic characteristics of the host. Epstein-Barr virus, a linear double-stranded DNA virus (herpesvirus), and the human T-cell leukemia virus, a retrovirus with a single-stranded diploid

APA, Harvard, Vancouver, ISO, and other styles

8

Franchini, Genoveffa, Richard F. Ambinder, and Michèle Barry. "Viral Disease in Hematology." Hematology 2000, no. 1 (2000): 409–23. http://dx.doi.org/10.1182/asheducation.v2000.1.409.409.

Full text

Abstract:

Abstract As part of the international outreach of the American Society of Hematology, this review addresses some aspects of the genetics, biology, epidemiology, and clinical relevance of viruses that cause a variety of hematopoietic disorders in human populations. The viruses described here have a different pattern of geographical distribution, and the disease manifestations may vary according to environmental and/or genetic characteristics of the host. Epstein-Barr virus, a linear double-stranded DNA virus (herpesvirus), and the human T-cell leukemia virus, a retrovirus with a single-stranded

APA, Harvard, Vancouver, ISO, and other styles

9

Burgart, L. J. "Cholangitis in viral disease." Mayo Clinic Proceedings 73, no. 5 (1998): 479–82. http://dx.doi.org/10.4065/73.5.479.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Liesegang, Thomas J. "Varicella Zoster Viral Disease." Mayo Clinic Proceedings 74, no. 10 (1999): 983–98. http://dx.doi.org/10.4065/74.10.983.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Capeau, Jacqueline, Lawrence Serfaty, and Mostafa Badr. "PPARs in Viral Disease." PPAR Research 2009 (2009): 1–2. http://dx.doi.org/10.1155/2009/393408.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Franchini, G. "Viral Disease in Hematology." Hematology 2000, no. 1 (2000): 409–23. http://dx.doi.org/10.1182/asheducation-2000.1.409.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Burgart, Lawrence J. "Cholangitis in Viral Disease." Mayo Clinic Proceedings 73, no. 5 (1998): 479–82. http://dx.doi.org/10.1016/s0025-6196(11)63735-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Liesegang, Thomas J. "Varicella Zoster Viral Disease." Mayo Clinic Proceedings 74, no. 10 (1999): 983–98. http://dx.doi.org/10.1016/s0025-6196(11)63996-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

J Buchmeier, Michael, and Thomas E Lane. "Viral-induced neurodegenerative disease." Current Opinion in Microbiology 2, no. 4 (1999): 398–402. http://dx.doi.org/10.1016/s1369-5274(99)80070-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Vasconcelos, Pedro FC. "Diagnosis of viral disease." Lancet 361, no. 9369 (2003): 1589. http://dx.doi.org/10.1016/s0140-6736(03)13307-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Friedland, J. S. "Chemokines in viral disease." Research in Virology 147, no. 2-3 (1996): 131–38. http://dx.doi.org/10.1016/0923-2516(96)80227-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Anderson, Monique R., Fatah Kashanchi, and Steven Jacobson. "Exosomes in Viral Disease." Neurotherapeutics 13, no. 3 (2016): 535–46. http://dx.doi.org/10.1007/s13311-016-0450-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Weber, T., P. Kennedy, and M. Oette. "Viral neuropathogenesis/Prion disease." Journal of Neurovirology 8, no. 3 (2002): 105–13. http://dx.doi.org/10.1080/13550280290100662.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Nevoralová, Zuzana. "ORF - rare viral disease." Dermatologie pro praxi 18, no. 4 (2024): 198–201. https://doi.org/10.36290/der.2024.039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Ahmed, Jamal Uddin, Muhammad Abdur Rahim, and Khwaja Nazim Uddin. "Emerging Viral Diseases." BIRDEM Medical Journal 7, no. 3 (2017): 224–32. http://dx.doi.org/10.3329/birdem.v7i3.33785.

Full text

Abstract:

Human life is intricately related to its surrounding environment which also harbors other animals and some deadly infectious pathogens. Any threat to the environment can thus increase the threat of new and so-called emerging infectious diseases (EIDs) especially novel viral infections called emerging viral diseases. This occurs partly due to changing climate as well as human interference with nature and animal life. An important event in new disease emergence is genetic changes in the pathogen that make it possible to become established in a new host species, productively infect new indiv

APA, Harvard, Vancouver, ISO, and other styles

22

Frölich, K. "Viral diseases of northern ungulates." Rangifer 20, no. 2-3 (2000): 83. http://dx.doi.org/10.7557/2.20.2-3.1505.

Full text

Abstract:

This paper describes viral diseases reported in northern ungulates and those that are a potential threat to these species. The following diseases are discussed: bovine viral diarrhoea/mucosal disease (BVD/MD), alphaherpesvirus infections, malignant catarrhal fever (MCF), poxvirus infections, parainfluenza type 3 virus infection, Alvsborg disease, foot-and-mouth disease, epizootic haemorrhage disease of deer and bluetongue disease, rabies, respiratory syncytial virus infection, adenovirus infection, hog-cholera, Aujeszky's disease and equine herpesvirus infections. There are no significant diff

APA, Harvard, Vancouver, ISO, and other styles

23

Donnelly, Thomas M. "Emerging viral diseases of rabbits and rodents: Viral hemorrhagic disease and hantavirus infection." Seminars in Avian and Exotic Pet Medicine 4, no. 2 (1995): 83–91. http://dx.doi.org/10.1016/s1055-937x(05)80043-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Braselton, James P., and Martha L. Abell. "A Viral Disease That Damages the Immunity Conferred by Different Viral Diseases or Vaccination." Mathematics 9, no. 8 (2021): 808. http://dx.doi.org/10.3390/math9080808.

Full text

Abstract:

In this paper we modify a standard SIR model used to study the spread of some diseases by incorporating a disease that destroys the immunity that is conferred by having one of the other diseases or being vaccinated against the disease. A specific biological example of this occurs with measles. Studies of recent measles’ patients has shown that many patients have lost some (or all) of their immunity to other diseases from which they were previously protected. In the future, models like those developed here might be helpful in understanding how viruses that affect multiple organ systems can impa

APA, Harvard, Vancouver, ISO, and other styles

25

Anupriya, Surendra Singh Shekhawat Subhash Chand Meena Vipin Chand Bairwa and Neelam Meena. "Lumpy skin disease: An emerging viral disease." Science World a monthly e magazine 3, no. 9 (2023): 2276–78. https://doi.org/10.5281/zenodo.8349280.

Full text

Abstract:

The likelihood of the disease spreading to other parts of Asia and Europe is higher for lumpy skin disease, a developing bovine viral disease that is widespread in most African and some Middle Eastern nations. Understanding the restrictions and channels of distribution is crucial given the recent quick propagation of infectious diseases in nations that are currently disease-free. Capripoxvirus, the responsible agent, may result in goatpox and sheeppox. Given that they pose a threat to global trade and may be exploited as tools of financial bioterrorism, the economic impact of these illnesses i

APA, Harvard, Vancouver, ISO, and other styles

26

Y, Nesradin. "Update on Veterinary Viral Vaccines: A Review." Open Access Journal of Veterinary Science & Research 3, no. 3 (2018): 1–12. http://dx.doi.org/10.23880/oajvsr-16000163.

Full text

Abstract:

Vaccine has made a very significant impact on the control of viral diseases in both humans and animal species. Worldwide eradication of small pox and rinderpest an d drastic reduction in other infection disease are confirming to the fact that vaccination is the most feasible and cost effective strategy for prevention, control and eradication of infectious disease. Veterinary science has made a significant contributio n to the field of vaccine research and development. Among the numerous of infectious diseases in animals, those of viral etiology account for a high burden of cases and they are t

APA, Harvard, Vancouver, ISO, and other styles

27

Christo, Paulo P., Dirceu B. Greco, Agdemir W. Aleixo, and Jose A. Livramento. "HIV-1 RNA levels in cerebrospinal fluid and plasma and their correlation with opportunistic neurological diseases in a Brazilian AIDS reference hospital." Arquivos de Neuro-Psiquiatria 63, no. 4 (2005): 907–13. http://dx.doi.org/10.1590/s0004-282x2005000600001.

Full text

Abstract:

BACKGROUND: Plasma HIV RNA levels reflect systemic viral replication but in CNS it may occur relatively independent of systemic infection, yet clinical application of CSF HIV-1 RNA levels is less clear. OBJECTIVE: to compare CSF and plasma HIV-1 RNA levels of patients with different opportunistic neurological diseases to those without neurological disease, as well as to correlate these levels with the outcome of the disease and use of HAART. METHOD: 97 patients who had lumbar puncture for routine work up of suspected neurological diseases, were divided in 2 groups: without neurological disease

APA, Harvard, Vancouver, ISO, and other styles

28

Soloviov, S. O., I.V Dzyublyk, O.M Zaliska, and A. O. Sakhno. "ANALYTICAL JUSTIFICATION OF INCLUDING THE ANTIVIRAL DRUG INTO TREATMENT SCHEME FOR PATIENTS WITH SUSPECTED VIRAL DISEASE." Annals of Mechnikov Institute, no. 4 (December 2, 2016): 18–26. https://doi.org/10.5281/zenodo.192296.

Full text

Abstract:

Background: Viruses play a leading role in human pathology development, causing a large number of infectious diseases in acute, persistent or chronic forms. Although the number of deaths caused by viral infections have decreased significantly today, they continue to be a significant factor in reducing of the population overall productivity. Viral diseases cause additional losses in community related to the duration of the course or disease or its chronization, increased use of health care, loss of working hours, premature death etc. Introduction of the new antiviral drugs into medical practice

APA, Harvard, Vancouver, ISO, and other styles

29

Sait, Ahmad, Cristian Angeli, Andrew J. Doig, and Philip J. R. Day. "Viral Involvement in Alzheimer’s Disease." ACS Chemical Neuroscience 12, no. 7 (2021): 1049–60. http://dx.doi.org/10.1021/acschemneuro.0c00719.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Abrahams, I. Williard. "Viral Disease of the Eye." Ophthalmic Surgery, Lasers and Imaging Retina 18, no. 7 (1987): 547. http://dx.doi.org/10.3928/1542-8877-19870701-24.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

CLIVER, DEAN O. "Epidemiology of Viral Foodborne Disease." Journal of Food Protection 57, no. 3 (1994): 263–66. http://dx.doi.org/10.4315/0362-028x-57.3.263.

Full text

Abstract:

Virus transmission via foods begins with fecal shedding of viruses by humans. Foodborne viruses infect perorally: These same agents have alterative fecal-oral routes, including person- to-person transmission and the water vehicle. No zoonotic viruses are transmitted via foods in North America. Viruses rank high among foodborne disease agents in the United States, even though observation, diagnosis, and reporting of foodborne viral disease are inefficient. Risk assessment in developed countries considers viral infection rates and personal hygiene of food handlers, as well as the opportunities f

APA, Harvard, Vancouver, ISO, and other styles

32

von Lichtenberg, Franz. "Viral Hepatitis and Liver Disease." American Journal of Tropical Medicine and Hygiene 39, no. 4 (1988): 417. http://dx.doi.org/10.4269/ajtmh.1988.39.4.tm0390040417a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Aterman, K. "Neonatal Hepatitis-A Viral Disease?" Pediatric Pathology 9, no. 3 (1989): 243–50. http://dx.doi.org/10.3109/15513818909037729.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Tam, Paul K. H., W. G. V. Quint, and D. Van Velzen. "Hirschsprung's Disease: A Viral Etiology?" Pediatric Pathology 12, no. 6 (1992): 807–10. http://dx.doi.org/10.3109/15513819209024237.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Busse, William W. "Viral infections and allergic disease." Clinical Experimental Allergy 21, s1 (1991): 68–71. http://dx.doi.org/10.1111/j.1365-2222.1991.tb01708.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Takahashi, Mitsuo, and Tatsuo Yamada. "Viral Etiology for Parkinson's Disease." Japanese Journal of Infectious Diseases 52, no. 3 (1999): 89–98. http://dx.doi.org/10.7883/yoken.52.89.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Aitken, Celia, and Donald J. Jeffries. "Nosocomial Spread of Viral Disease." Clinical Microbiology Reviews 14, no. 3 (2001): 528–46. http://dx.doi.org/10.1128/cmr.14.3.528-546.2001.

Full text

Abstract:

SUMMARY Viruses are important causes of nosocomial infection, but the fact that hospital outbreaks often result from introduction(s) from community-based epidemics, together with the need to initiate specific laboratory testing, means that there are usually insufficient data to allow the monitoring of trends in incidences. The most important defenses against nosocomial transmission of viruses are detailed and continuing education of staff and strict adherence to infection control policies. Protocols must be available to assist in the management of patients with suspected or confirmed viral inf

APA, Harvard, Vancouver, ISO, and other styles

38

&NA;. "Effective Drugs Against Viral Disease." Nurse Practitioner 27, no. 8 (2002): 46. http://dx.doi.org/10.1097/00006205-200208000-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Goncharov, G. D. "RUBELLA, A VIRAL FISH DISEASE." Annals of the New York Academy of Sciences 126, no. 1 (2006): 598–600. http://dx.doi.org/10.1111/j.1749-6632.1965.tb14305.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Hudson, Robert J. "Disease Surveillance versus Viral Surveillance." Clinical Infectious Diseases 33, no. 2 (2001): 265–66. http://dx.doi.org/10.1086/321822.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Sheppard, Haynes W., Michael S. Ascher, and John F. Krowka. "Viral burden and HIV disease." Nature 364, no. 6435 (1993): 291. http://dx.doi.org/10.1038/364291a0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Fauci, Antony S., Giuseppe Pantaleo, Janet Embretson, and Ashley T. Haase. "Viral burden and HIV disease." Nature 364, no. 6435 (1993): 291–92. http://dx.doi.org/10.1038/364291b0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Tibell, A., and C. G. Groth. "No viral disease after xenotransplantation." Nature 392, no. 6677 (1998): 646. http://dx.doi.org/10.1038/33517.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Meldrum, K. "Viral haemorrhagic disease of rabbits." Veterinary Record 130, no. 18 (1992): 407. http://dx.doi.org/10.1136/vr.130.18.407-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Greenberg, Harry B., and Pedro A. Piedra. "Immunization Against Viral Respiratory Disease." Pediatric Infectious Disease Journal 23, Supplement (2004): S254—S261. http://dx.doi.org/10.1097/01.inf.0000144756.69887.f8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Rovner, Daniel, and Leslie Weiner. "Chronic Viral Disease of Myelin." Seminars in Neurology 5, no. 02 (1985): 168–79. http://dx.doi.org/10.1055/s-2008-1041513.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Englund, Janet, W. Paul Glezen, and Pedro A. Piedra. "Maternal immunization against viral disease." Vaccine 16, no. 14-15 (1998): 1456–63. http://dx.doi.org/10.1016/s0264-410x(98)00108-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Longman, Ryan E., and Timothy R. B. Johnson. "Viral Respiratory Disease in Pregnancy." Postgraduate Obstetrics & Gynecology 27, no. 22 (2007): 1–6. http://dx.doi.org/10.1097/01.pgo.0000299203.10579.50.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

&NA;. "Viral Respiratory Disease in Pregnancy." Postgraduate Obstetrics & Gynecology 27, no. 22 (2007): 7–8. http://dx.doi.org/10.1097/01.pgo.0000299204.48697.9c.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Black, Benjamin O., Séverine Caluwaerts, and Jay Achar. "Ebola viral disease and pregnancy." Obstetric Medicine 8, no. 3 (2015): 108–13. http://dx.doi.org/10.1177/1753495x15597354.

Full text

Abstract:

Ebola viral disease’s interaction with pregnancy is poorly understood and remains a particular challenge for medical and para-medical personnel responding to an outbreak. This review article is written with the benefit of hindsight and experience from the largest recorded Ebola outbreak in history. We have provided a broad overview of the issues that arise for pregnant women and for the professionals treating them during an Ebola outbreak. The discussion focuses on the specifics of Ebola infection in pregnancy and possible management strategies, including the delivery of an infected woman. We

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!